| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Venker Eric | President & Immunovant CEO | Sale+OE | 200,000 | $21.92 | $4,384,000.00 | -10.8% | → |
| 2025-12-31 | Sukhatme Mayukh | President & CIO | Sale+OE | 1,330,868 | $21.72 | $28,902,500.47 | -3.3% | → |
| 2025-12-24 | Venker Eric | President & Immunovant CEO | Sale+OE | 275,000 | $22.47 | $6,179,750.00 | -7.8% | → |
| 2025-12-23 | Pulik Richard | CFO | Sale+OE | 406,731 | $22.43 | $9,122,307.09 | -39.4% | → |
| 2025-12-17 | Sukhatme Mayukh | President & CIO | Sale+OE | 26,831 | $23.09 | $619,527.79 | -0.1% | → |
| 2025-12-17 | QVT Financial LP | - | Sell | 1,694,614 | $23.05 | $39,065,213.44 | -2.0% | → |
| 2025-12-17 | Gold Daniel Allen | - | Sell | 1,694,614 | $23.05 | $39,065,213.44 | -2.0% | → |
| 2025-12-17 | MANCHESTER KEITH S | - | Sell | 1,694,614 | $23.05 | $39,065,213.44 | -2.0% | → |
| 2025-12-15 | Gline Matthew | CEO | Sale+OE | 1,740,000 | $21.68 | $37,723,200.00 | -3.1% | → |
| 2025-12-15 | Ramaswamy Vivek | 10% Owner | Sale+OE | 3,103,745 | $21.89 | $67,942,351.81 | -2.9% | → |
| 2025-12-12 | Roivant Sciences Ltd. | - | Buy | 16,666,666 | $21.00 | $349,999,986.00 | +17.2% | → |
| 2025-12-09 | Venker Eric | President & Immunovant CEO | Sale+OE | 200,000 | $20.85 | $4,170,000.00 | -11.8% | → |
| 2025-11-19 | MANCHESTER KEITH S | - | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | → |
| 2025-11-19 | QVT Financial LP | - | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | → |
| 2025-11-19 | Gold Daniel Allen | - | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | → |
| 2025-11-17 | Ramaswamy Vivek | 10% Owner | Sell | 1,854,603 | $20.46 | $37,939,111.83 | -1.8% | → |
| 2025-11-07 | Venker Eric | President & Immunovant CEO | Sale+OE | 200,000 | $20.22 | $4,044,000.00 | -11.7% | → |
| 2025-10-17 | Venker Eric | President & Immunovant CEO | Sale+OE | 851,383 | $16.99 | $14,467,502.37 | -15.9% | → |